The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial

Tegaserod, a 5‐HT₄ receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

S. Müller‐Lissner, I. Fumagalli, Karna Dev Bardhan et al. · Alimentary Pharmacology & Therapeutics · 2001 · 464 citations · Full text

Treatment of Irritable Bowel Syndrome With Chinese Herbal Medicine

Alan Bensoussan, Nick Talley, Michael Hing et al. · JAMA · 1998 · 418 citations · Full text

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT₃ receptor antagonist

Camilleri, Mayer, Drossman et al. · Alimentary Pharmacology & Therapeutics · 1999 · 372 citations · Full text

The epidemiology of irritable bowel syndrome

2014 · 346 citations · Full text

Causality Assessment in Drug-Induced Liver Injury Using A Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method

Don C. Rockey, Leonard B. Seeff, James Rochon et al. · Hepatology · 2010 · 333 citations · Full text